RAPT Therapeutics, Inc. (RAPT)
NASDAQ: RAPT · Real-Time Price · USD
0.825
+0.018 (2.18%)
At close: Dec 20, 2024, 4:00 PM
0.850
+0.024 (2.93%)
After-hours: Dec 20, 2024, 5:08 PM EST
RAPT Therapeutics Market Cap
RAPT Therapeutics has a market cap or net worth of $28.85 million as of December 20, 2024. Its market cap has decreased by -95.21% in one year.
Market Cap
28.85M
Enterprise Value
-63.93M
1-Year Change
-95.21%
Ranking
Category
Stock Price
$0.83
Market Cap Chart
Since October 31, 2019, RAPT Therapeutics's market cap has decreased from $276.64M to $28.85M, a decrease of -89.57%. That is a compound annual growth rate of -35.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 28.85M | -96.62% |
| Dec 29, 2023 | 854.75M | 27.19% |
| Dec 30, 2022 | 672.02M | -38.08% |
| Dec 31, 2021 | 1.09B | 123.77% |
| Dec 31, 2020 | 484.97M | -19.54% |
| Dec 31, 2019 | 602.76M | 117.89% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chemomab Therapeutics | 29.79M |
| Intensity Therapeutics | 29.67M |
| OneMedNet | 29.67M |
| IGC Pharma | 29.04M |
| ProMIS Neurosciences | 28.92M |
| Calidi Biotherapeutics | 28.49M |
| IRIDEX | 28.12M |
| RenovoRx | 27.94M |